Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Solid Biosciences Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +3 vs. Q3 2023
- Shares held
- 16.6M
- +463.8K (+2.9%) vs. Q3 2023
- Total value
- $102.2M
- +$61.5M (+150.9%) vs. Q3 2023
- New holders
- 8
- 12 more added
- Sold out
- 5
- 6 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLDB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.14B |
| Q1 2026 | 150 | $717.4M |
| Q4 2025 | 132 | $459.2M |
| Q3 2025 | 129 | $505.2M |
| Q2 2025 | 116 | $403.4M |
| Q1 2025 | 125 | $293.2M |
| Q4 2024 | 90 | $145.3M |
| Q3 2024 | 92 | $249.8M |
| Q2 2024 | 80 | $213.2M |
| Q1 2024 | 56 | $465.9M |
| Q4 2023 | 40 | $102.2M |
| Q3 2023 | 37 | $40.7M |
| Q2 2023 | 36 | $85.6M |
| Q1 2023 | 39 | $74.8M |
| Q4 2022 | 35 | $85.6M |
| Q3 2022 | 58 | $33.4M |
| Q2 2022 | 67 | $39.5M |
| Q1 2022 | 78 | $83.3M |
| Q4 2021 | 82 | $132.2M |
| Q3 2021 | 91 | $184.3M |
| Q2 2021 | 92 | $293.4M |
| Q1 2021 | 104 | $437.6M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Solid Biosciences Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 0 | $6 | 0.00% | 0 | Unchanged |
| FMR LLC | 6 | $37 | 0.00% | −294−98.0% | Reduced |
| Parallel Advisors, LLC | 6 | $37 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 30 | $184 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 75 | $461 | 0.00% | +6+8.7% | Added |
| First Manhattan Co | 133 | $816 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 133 | $817 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 537 | $3.00K | 0.00% | +510+1,888.9% | Added |
| Hantz Financial Services, Inc. | 666 | $4.00K | 0.00% | +666 | New |
| ADAR1 Capital Management, LLC | 1,000 | $6.14K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 1,555 | $9.55K | 0.00% | +67+4.5% | Added |
| Royal Bank of Canada | 3,060 | $18.0K | 0.00% | +512+20.1% | Added |
| AJOVista, LLC | 3,806 | $23.4K | 0.03% | +3,806 | New |
| Bank of America Corp | 3,959 | $24.3K | 0.00% | +1,633+70.2% | Added |
| UBS Group AG | 4,024 | $24.7K | 0.00% | +4,009+26,726.7% | Added |
| Morgan Stanley | 4,233 | $26.0K | 0.00% | −365−7.9% | Reduced |
| Barclays PLC | 4,417 | $27.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 28,257 | $173.5K | 0.00% | +16,823+147.1% | Added |
| Susquehanna International Group, LLP | 33,235 | $204.1K | 0.00% | +33,235 | New |
| Vestal Point Capital, LP | 34,085 | $209.3K | 0.02% | +34,085 | New |
| Two Sigma Investments, LP | 37,198 | $228.4K | 0.00% | +37,198 | New |
| Renaissance Technologies LLC | 38,071 | $234.0K | 0.00% | +9,501+33.3% | Added |
| State Street Corp | 44,594 | $273.8K | 0.00% | +31,200+232.9% | Added |
| Dimensional Fund Advisors LP | 49,950 | $306.7K | 0.00% | −5,140−9.3% | Reduced |
| Bridgeway Capital Management, LLC | 51,057 | $313.5K | 0.01% | +15,000+41.6% | Added |
| Geode Capital Management, LLC | 93,501 | $574.2K | 0.00% | −9,012−8.8% | Reduced |
| BlackRock Inc. | 114,098 | $700.6K | 0.00% | −17,185−13.1% | Reduced |
| Walleye Capital LLC | 124,560 | $764.8K | 0.01% | +33,451+36.7% | Added |
| Bank of Montreal | 131,500 | $900.8K | 0.00% | +131,500 | New |
| Vanguard Group Inc | 324,171 | $1.99M | 0.00% | +74,111+29.6% | Added |
| Silverarc Capital Management, LLC | 594,855 | $3.65M | 1.13% | +594,855 | New |
| Alyeska Investment Group, L.P. | 637,279 | $3.91M | 0.03% | −9,325−1.4% | Reduced |
| Artal Group S.A. | 909,219 | $5.58M | 0.19% | 00.0% | Unchanged |
| Laurion Capital Management LP | 928,169 | $5.70M | 0.20% | 00.0% | Unchanged |
| Finepoint Capital LP | 961,251 | $5.90M | 2.04% | 00.0% | Unchanged |
| Camber Capital Management LP | 1,418,439 | $8.71M | 0.30% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 3,130,422 | $19.2M | 1.84% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,426,286 | $21.0M | 0.33% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,495,933 | $21.5M | 0.48% | 00.0% | Unchanged |
| Great Point Partners LLC | 0 | $0 | 0.00% | −450,403−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −64,112−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,332−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −214−100.0% | Sold out |